Funders › CT › Rett Syndrome Research Trust Inc › 2020
Grants paid by Rett Syndrome Research Trust Inc, tax year 2020
EIN 26-0687439 · Trumbull, CT · Form 990, Schedule I · NTEE E12
In tax year 2020, Rett Syndrome Research Trust Inc (EIN 26-0687439) reported 24 grants paid totaling $4,205,466. Dataset version 2026.09.0, built 2026-09-03.
Every grant, 2020
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2020 | Gene Therapy Consortium Trumbull, CT | U | $765,607 | paid | GENE THERAPY CONSORTIUM | 202131379349300313 |
| 2020 | University of Massashussets Medical School Worcester, MA | A | $533,759 | paid | RNA/DNA EDITING;READTHROUGH THERAPY; MECP2 DUPLICATION SYNDROME | 202131379349300313 |
| 2020 | Mecp2 Consortium Trumbull, CT | U | $450,000 | paid | MECP2 CONSORTIUM | 202131379349300313 |
| 2020 | Beam Therapeutics Cambridge, MA | U | $426,200 | paid | DNA EDITING | 202131379349300313 |
| 2020 | Clinical Trial Consortium Trumbull, CT | U | $418,578 | paid | CLINICAL TRIAL CONSORTIUM | 202131379349300313 |
| 2020 | Massachusetts Institute of Technology Cambridge, MA | A | $356,166 | paid | RNA EDITING | 202131379349300313 |
| 2020 | Ombd Consortium Trumbull, CT | U | $278,174 | paid | OMBD CONSORTIUM | 202131379349300313 |
| 2020 | University of California Berkley Berkeley, CA | U | $186,074 | paid | PROTEIN REPLACEMENT | 202131379349300313 |
| 2020 | Hospital for Sick Children Trumbull, CT | U | $95,000 | paid | GENOME EDITING FOR MECP2 DUPLICATION SYNDROME | 202131379349300313 |
| 2020 | Baylor College of Medicine Houston, TX | A | $93,497 | paid | PRECLINICAL DRUG DEVELOPMENT-MECP2 DUPLICATION SYNDROME | 202131379349300313 |
| 2020 | University of California Davis Davis, CA | A | $70,586 | paid | RNA EDITING | 202131379349300313 |
| 2020 | University of Edinburgh Trumbull, CT | U | $70,076 | paid | GENE REPLACEMENT; RNA TRANSPLICING | 202131379349300313 |
| 2020 | Queen Mary Iniversity of London Trumbull, CT | U | $58,504 | paid | MECP2 REACTIVATION | 202131379349300313 |
| 2020 | Oregon Health and Sciences University Foundation Portland, OR | A | $57,500 | paid | RNA EDITING | 202131379349300313 |
| 2020 | Whitehead Institute of Biomedical Research Cambridge, MA | A | $49,988 | paid | MECP2 REACTIVATION | 202131379349300313 |
| 2020 | Ciitizen Corporation Palo Alto, CA | U | $48,885 | paid | DIGITAL NATIONAL REGISTRY | 202131379349300313 |
| 2020 | California Institute of Technologies Pasadena, CA | C | $47,299 | paid | MEPC2 REGULATION | 202131379349300313 |
| 2020 | Ketamine Trial Trumbull, CT | U | $46,430 | paid | PRE-CLINICAL TESTING OF KETAMINE COMPOUNDS | 202131379349300313 |
| 2020 | Dsg Malvern, PA | U | $42,000 | paid | RETT SYNDROME GLOBAL REGISTRY | 202131379349300313 |
| 2020 | Coriell Institute for Medical Research Camden, NJ | B | $37,776 | paid | BIO REPOSITORY | 202131379349300313 |
| 2020 | Emerald Innovations Cambridge, MA | U | $33,169 | paid | OUTCOME MEASURES | 202131379349300313 |
| 2020 | Rett Syndrome Center at Montefiore Medical Center Bronx, NY | A | $25,000 | paid | RETT CLINIC | 202131379349300313 |
| 2020 | Jackson Laboraties Bar Harbor, ME | D | $11,500 | paid | MOUSE MODELS ALLELIC SERIES | 202131379349300313 |
| 2020 | Charles River Wilmington, MA | C | $3,698 | paid | BIOMARKERS | 202131379349300313 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Derived from IRS Form 990 e-file XML. Dataset version 2026.09.0, built 2026-09-03. All years for this funder.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.